The Use of 2% Chlorhexidine Gluconate With Mineral Trioxide Aggregate in Indirect Pulp Treatment of Primary Molars

NCT ID: NCT04770792

Last Updated: 2021-09-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-04-06

Study Completion Date

2021-06-08

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study was to compare the clinical and radiographic success rates of indirect pulp treatment (IPT) performed by combining 2% chlorhexidine gluconate with mineral trioxide aggregate (MTA) versus IPT performed with MTA in children's vital primary molars. A randomized, split-mouth design including 40 children aged 4-8 years was implemented. The study sample composed of 80 primary molars with deep carious lesions. Each child had 1 pair, one tooth from each pair was allocated randomly either to the 2% chlorhexidine gluconate/MTA group or the MTA group. All teeth were restored with stainless steel crowns. Follow-up is carried out to evaluate the teeth clinically and radiographically.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A double blinded, randomized, controlled clinical trial was performed in a split-mouth design. Eighty primary molars in forty subjects were randomly allocated that each subject had one tooth treated with 2% chlorhexidine gluconate and MTA (experimental group), and the other tooth treated with only MTA (control group).

The study was held at King Abdulaziz University Dental Hospital (KAUDH), Jeddah. Forty healthy children with the age range 4- to 8-year-old were included. Each patient had at least two first primary molars or two second primary molars with deep occlusal or proximal caries not approaching the pulp indicated for IPT.

Preoperative periapical radiographs of the teeth considered for treatment in the study were made using extension cone paralleling technique in the x ray machine.

The procedure was performed in two visits by one operator to allow for the setting of MTA. Stainless steel crowns were used as final restorations.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Indirect Pulp Treatment

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Experimental group

2% chlorhexidine gluconate with mineral trioxide aggregate.

Group Type EXPERIMENTAL

2% chlorhexidine gluconate with mineral trioxide aggregate.

Intervention Type OTHER

2% chlorhexidine gluconate with mineral trioxide aggregate.

Control group

Mineral trioxide aggregate.

Group Type ACTIVE_COMPARATOR

Mineral trioxide aggregate.

Intervention Type OTHER

Mineral trioxide aggregate.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

2% chlorhexidine gluconate with mineral trioxide aggregate.

2% chlorhexidine gluconate with mineral trioxide aggregate.

Intervention Type OTHER

Mineral trioxide aggregate.

Mineral trioxide aggregate.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 4-8 years old.
* Healthy.
* Cooperative.
* Had at least two first primary molars or two second primary molars with deep occlusal or proximal caries not approaching the pulp indicated for IPT.


* No spontaneous pain.
* No pain on palpation or percussion.
* No signs of fistula or abscess.
* No abnormal mobility.
* No radiolucency at the periapical or interradicular areas.
* No loss of lamina dura.
* No radiographic signs of internal resorption.
* Sufficient tooth structure allowing placement of rubber dam.
* Not expected to exfoliate within 1 year.

Exclusion Criteria

* Spontaneous pain.
* Pain on palpation or percussion.
* Signs of fistula or abscess.
* Presence of abnormal mobility.
* Radiolucency at the periapical or interradicular areas.
* Loss of lamina dura.
* Radiographic signs of internal resorption.
* No sufficient tooth structure allowing placement of rubber dam.
* Expected to exfoliate within 1 year.
Minimum Eligible Age

4 Years

Maximum Eligible Age

8 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

King Abdulaziz University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Afnan Saber

Principle investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Afnan M Saber, MSc

Role: PRINCIPAL_INVESTIGATOR

Phd student at Pediatric Dentistry Department, Faculty of Dentistry, King Abdulaziz University.

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

King Abdulaziz University

Jeddah, Mecca Region, Saudi Arabia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Saudi Arabia

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ASaber

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.